In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 21st, 2005 | 27 | Yes |
Popular Name: JNJ-7706621 JNJ-7706621
Find On: PubMed — Wikipedia — Google
CAS Numbers: 443797-96-4 , [443797-96-4]
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.97 | 5.91 | -18.67 | 5 | 9 | 0 | 146 | 394.363 | 4 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Target | CDK, Aurora Kinase | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AAK1-1-E | Adaptor-associated Kinase (cluster #1 Of 2), Eukaryotic | Eukaryotes | 200 | 0.35 | Binding ≤ 10μM |
AAPK1-1-E | AMP-activated Protein Kinase, Alpha-1 Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.30 | Binding ≤ 10μM |
AAPK2-1-E | AMP-activated Protein Kinase, Alpha-2 Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1800 | 0.30 | Binding ≤ 10μM |
ABL1-1-E | Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic | Eukaryotes | 820 | 0.32 | Binding ≤ 10μM |
ACVL1-1-E | Serine/threonine-protein Kinase Receptor R3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2900 | 0.29 | Binding ≤ 10μM |
ACVR1-1-E | Activin Receptor Type-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5900 | 0.27 | Binding ≤ 10μM |
ADCK3-1-E | Chaperone Activity Of Bc1 Complex-like, Mitochondrial (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1200 | 0.31 | Binding ≤ 10μM |
ALK-1-E | ALK Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7100 | 0.27 | Binding ≤ 10μM |
ANKK1-1-E | Ankyrin Repeat And Protein Kinase Domain-containing Protein 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 500 | 0.33 | Binding ≤ 10μM |
AURKA-3-E | Serine/threonine-protein Kinase Aurora-A (cluster #3 Of 3), Eukaryotic | Eukaryotes | 250 | 0.34 | Binding ≤ 10μM |
AURKB-1-E | Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic | Eukaryotes | 160 | 0.35 | Binding ≤ 10μM |
AURKC-1-E | Serine/threonine-protein Kinase Aurora-C (cluster #1 Of 2), Eukaryotic | Eukaryotes | 86 | 0.37 | Binding ≤ 10μM |
AVR2A-1-E | Activin Receptor Type-2A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2900 | 0.29 | Binding ≤ 10μM |
AVR2B-1-E | Activin Receptor Type-2B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5900 | 0.27 | Binding ≤ 10μM |
BMP2K-1-E | BMP-2-inducible Protein Kinase (cluster #1 Of 2), Eukaryotic | Eukaryotes | 180 | 0.35 | Binding ≤ 10μM |
BMPR2-1-E | Bone Morphogenetic Protein Receptor Type-2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 880 | 0.31 | Binding ≤ 10μM |
BMX-1-E | Tyrosine-protein Kinase BMX (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4700 | 0.28 | Binding ≤ 10μM |
BRSK1-1-E | BR Serine/threonine-protein Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6500 | 0.27 | Binding ≤ 10μM |
BRSK2-1-E | BR Serine/threonine-protein Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2700 | 0.29 | Binding ≤ 10μM |
CCNA1-1-E | Cyclin A1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2 | 0.45 | Binding ≤ 10μM |
CCNA2-1-E | Cyclin A2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2 | 0.45 | Binding ≤ 10μM |
CCNB1-1-E | G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 6 | 0.43 | Binding ≤ 10μM |
CCNB2-1-E | G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 6 | 0.43 | Binding ≤ 10μM |
CCNB3-1-E | G2/mitotic-specific Cyclin B3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 6 | 0.43 | Binding ≤ 10μM |
CD11A-1-E | PITSLRE Serine/threonine-protein Kinase CDC2L2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 110 | 0.36 | Binding ≤ 10μM |
CD11B-1-E | PITSLRE Serine/threonine-protein Kinase CDC2L1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 150 | 0.35 | Binding ≤ 10μM |
CDK1-1-E | Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 6 | 0.43 | Binding ≤ 10μM |
CDK14-1-E | Serine/threonine-protein Kinase PFTAIRE-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3600 | 0.28 | Binding ≤ 10μM |
CDK16-1-E | Serine/threonine-protein Kinase PCTAIRE-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 23 | 0.40 | Binding ≤ 10μM |
CDK17-1-E | Serine/threonine-protein Kinase PCTAIRE-2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 290 | 0.34 | Binding ≤ 10μM |
CDK18-1-E | Serine/threonine-protein Kinase PCTAIRE-3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.29 | Binding ≤ 10μM |
CDK2-1-E | Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 23 | 0.40 | Binding ≤ 10μM |
CDK3-1-E | Cyclin-dependent Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 180 | 0.35 | Binding ≤ 10μM |
CDK5-1-E | Cyclin-dependent Kinase 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 240 | 0.34 | Binding ≤ 10μM |
CDK7-1-E | Cyclin-dependent Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 760 | 0.32 | Binding ≤ 10μM |
CDK9-1-E | Cyclin-dependent Kinase 9 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 470 | 0.33 | Binding ≤ 10μM |
CLK1-1-E | Dual Specificty Protein Kinase CLK1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 660 | 0.32 | Binding ≤ 10μM |
CLK2-1-E | Dual Specificity Protein Kinase CLK2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 290 | 0.34 | Binding ≤ 10μM |
CLK3-1-E | Dual Specificity Protein Kinase CLK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 310 | 0.34 | Binding ≤ 10μM |
CLK4-1-E | Dual Specificity Protein Kinase CLK4 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1700 | 0.30 | Binding ≤ 10μM |
CSF1R-1-E | Macrophage Colony-stimulating Factor 1 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4200 | 0.28 | Binding ≤ 10μM |
CSK22-1-E | Casein Kinase II Alpha (prime) (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2000 | 0.30 | Binding ≤ 10μM |
DAPK3-1-E | Death-associated Protein Kinase 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5200 | 0.27 | Binding ≤ 10μM |
DCLK1-1-E | Serine/threonine-protein Kinase DCLK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2500 | 0.29 | Binding ≤ 10μM |
DCLK2-1-E | Serine/threonine-protein Kinase DCLK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4500 | 0.28 | Binding ≤ 10μM |
DCLK3-1-E | Serine/threonine-protein Kinase DCLK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6500 | 0.27 | Binding ≤ 10μM |
DMPK-1-E | Myotonin-protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1200 | 0.31 | Binding ≤ 10μM |
E2AK2-1-E | Interferon-induced, Double-stranded RNA-activated Protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6300 | 0.27 | Binding ≤ 10μM |
E2AK4-1-E | Eukaryotic Translation Initiation Factor 2-alpha Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3900 | 0.28 | Binding ≤ 10μM |
EPHA7-1-E | Ephrin Type-A Receptor 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3100 | 0.29 | Binding ≤ 10μM |
FGFR1-1-E | Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 810 | 0.32 | Binding ≤ 10μM |
FGFR2-1-E | Fibroblast Growth Factor Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 680 | 0.32 | Binding ≤ 10μM |
FGFR3-1-E | Fibroblast Growth Factor Receptor 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 690 | 0.32 | Binding ≤ 10μM |
FGR-1-E | Tyrosine-protein Kinase FGR (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2000 | 0.30 | Binding ≤ 10μM |
FLT3-1-E | Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 850 | 0.31 | Binding ≤ 10μM |
GAK-1-E | Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2400 | 0.29 | Binding ≤ 10μM |
GSK3A-1-E | Glycogen Synthase Kinase-3 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 41 | 0.38 | Binding ≤ 10μM |
GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic | Eukaryotes | 950 | 0.31 | Binding ≤ 10μM |
IKKE-1-E | Inhibitor Of Nuclear Factor Kappa B Kinase Epsilon Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8300 | 0.26 | Binding ≤ 10μM |
IRAK3-1-E | Interleukin-1 Receptor-associated Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3400 | 0.28 | Binding ≤ 10μM |
JAK1-1-E | Tyrosine-protein Kinase JAK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 21 | 0.40 | Binding ≤ 10μM |
JAK2-1-E | Tyrosine-protein Kinase JAK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 220 | 0.35 | Binding ≤ 10μM |
JAK3-1-E | Tyrosine-protein Kinase JAK3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 180 | 0.35 | Binding ≤ 10μM |
KC1E-1-E | Casein Kinase I Epsilon (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3600 | 0.28 | Binding ≤ 10μM |
KC1G1-1-E | Casein Kinase I Gamma 1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1200 | 0.31 | Binding ≤ 10μM |
KC1G2-1-E | Casein Kinase I Gamma 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 740 | 0.32 | Binding ≤ 10μM |
KC1G3-1-E | Casein Kinase I Isoform Gamma-3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7900 | 0.26 | Binding ≤ 10μM |
KIT-1-E | Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 590 | 0.32 | Binding ≤ 10μM |
KKCC1-1-E | CaM-kinase Kinase Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2900 | 0.29 | Binding ≤ 10μM |
KKCC2-1-E | CaM-kinase Kinase Beta (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2600 | 0.29 | Binding ≤ 10μM |
KPCD-1-E | Protein Kinase C Delta (cluster #1 Of 4), Eukaryotic | Eukaryotes | 4500 | 0.28 | Binding ≤ 10μM |
KPCD1-1-E | Protein Kinase C Mu (cluster #1 Of 3), Eukaryotic | Eukaryotes | 8400 | 0.26 | Binding ≤ 10μM |
KPCD3-1-E | Protein Kinase C Nu (cluster #1 Of 3), Eukaryotic | Eukaryotes | 4200 | 0.28 | Binding ≤ 10μM |
KPCT-1-E | Protein Kinase C Theta (cluster #1 Of 3), Eukaryotic | Eukaryotes | 4400 | 0.28 | Binding ≤ 10μM |
KS6A1-1-E | Ribosomal Protein S6 Kinase Alpha 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4000 | 0.28 | Binding ≤ 10μM |
KS6A2-1-E | Ribosomal Protein S6 Kinase Alpha 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 410 | 0.33 | Binding ≤ 10μM |
KS6A4-1-E | Ribosomal Protein S6 Kinase Alpha 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3000 | 0.29 | Binding ≤ 10μM |
KSYK-1-E | Tyrosine-protein Kinase SYK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1300 | 0.31 | Binding ≤ 10μM |
LIMK1-1-E | LIM Domain Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 620 | 0.32 | Binding ≤ 10μM |
LIMK2-1-E | LIM Domain Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1000 | 0.31 | Binding ≤ 10μM |
M3K9-1-E | Mitogen-activated Protein Kinase Kinase Kinase 9 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3600 | 0.28 | Binding ≤ 10μM |
M4K1-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 120 | 0.36 | Binding ≤ 10μM |
M4K3-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 820 | 0.32 | Binding ≤ 10μM |
M4K5-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.29 | Binding ≤ 10μM |
MARK1-1-E | Serine/threonine-protein Kinase MARK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 620 | 0.32 | Binding ≤ 10μM |
MARK2-1-E | MAP/microtubule Affinity-regulating Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1200 | 0.31 | Binding ≤ 10μM |
MARK3-1-E | Serine/threonine-protein Kinase C-TAK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 600 | 0.32 | Binding ≤ 10μM |
MARK4-1-E | MAP/microtubule Affinity-regulating Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 660 | 0.32 | Binding ≤ 10μM |
MERTK-1-E | Proto-oncogene Tyrosine-protein Kinase MER (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.29 | Binding ≤ 10μM |
MET-1-E | Hepatocyte Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 650 | 0.32 | Binding ≤ 10μM |
MK04-1-E | Mitogen-activated Protein Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1600 | 0.30 | Binding ≤ 10μM |
MK06-1-E | Mitogen-activated Protein Kinase 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 480 | 0.33 | Binding ≤ 10μM |
MK07-1-E | Mitogen-activated Protein Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 520 | 0.33 | Binding ≤ 10μM |
MK08-1-E | Mitogen-activated Protein Kinase 8 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 1700 | 0.30 | Binding ≤ 10μM |
MK10-1-E | C-Jun N-terminal Kinase 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1300 | 0.31 | Binding ≤ 10μM |
MK15-1-E | Mitogen-activated Protein Kinase 15 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1100 | 0.31 | Binding ≤ 10μM |
MP2K1-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 1800 | 0.30 | Binding ≤ 10μM |
MP2K2-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5600 | 0.27 | Binding ≤ 10μM |
MP2K3-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1500 | 0.30 | Binding ≤ 10μM |
MP2K4-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 630 | 0.32 | Binding ≤ 10μM |
MP2K6-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1000 | 0.31 | Binding ≤ 10μM |
MST4-1-E | Serine/threonine-protein Kinase MST4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 210 | 0.35 | Binding ≤ 10μM |
MYLK-1-E | Myosin Light Chain Kinase, Smooth Muscle (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.29 | Binding ≤ 10μM |
NUAK1-1-E | NUAK Family SNF1-like Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 180 | 0.35 | Binding ≤ 10μM |
NUAK2-1-E | NUAK Family SNF1-like Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 26 | 0.39 | Binding ≤ 10μM |
PAK3-1-E | Serine/threonine-protein Kinase PAK 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.29 | Binding ≤ 10μM |
PAK4-1-E | Serine/threonine-protein Kinase PAK 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2300 | 0.29 | Binding ≤ 10μM |
PAK6-1-E | Serine/threonine-protein Kinase PAK6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.30 | Binding ≤ 10μM |
PAK7-1-E | Serine/threonine-protein Kinase PAK7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 830 | 0.32 | Binding ≤ 10μM |
PDPK1-1-E | 3-phosphoinositide Dependent Protein Kinase-1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3100 | 0.29 | Binding ≤ 10μM |
PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4000 | 0.28 | Binding ≤ 10μM |
PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 910 | 0.31 | Binding ≤ 10μM |
PI42B-1-E | Phosphatidylinositol-5-phosphate 4-kinase Type-2 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1300 | 0.31 | Binding ≤ 10μM |
PI51A-1-E | Phosphatidylinositol-4-phosphate 5-kinase Type-1 Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9200 | 0.26 | Binding ≤ 10μM |
PKN2-1-E | Protein Kinase N2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1900 | 0.30 | Binding ≤ 10μM |
PLK1-1-E | Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5000 | 0.27 | Binding ≤ 10μM |
PLK3-1-E | Serine/threonine-protein Kinase PLK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7100 | 0.27 | Binding ≤ 10μM |
PLK4-1-E | Serine/threonine-protein Kinase PLK4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 120 | 0.36 | Binding ≤ 10μM |
RET-1-E | Tyrosine-protein Kinase Receptor RET (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4200 | 0.28 | Binding ≤ 10μM |
RIOK1-1-E | Serine/threonine-protein Kinase RIO1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1100 | 0.31 | Binding ≤ 10μM |
RIOK3-1-E | Serine/threonine-protein Kinase RIO3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1200 | 0.31 | Binding ≤ 10μM |
RIPK1-1-E | Receptor-interacting Serine/threonine-protein Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1800 | 0.30 | Binding ≤ 10μM |
SIK1-1-E | Serine/threonine-protein Kinase SIK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2200 | 0.29 | Binding ≤ 10μM |
SIK2-1-E | Serine/threonine-protein Kinase SIK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1600 | 0.30 | Binding ≤ 10μM |
SLK-1-E | Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 48 | 0.38 | Binding ≤ 10μM |
SRPK1-1-E | Serine/threonine-protein Kinase SRPK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.29 | Binding ≤ 10μM |
ST17A-1-E | Serine/threonine-protein Kinase 17A (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5600 | 0.27 | Binding ≤ 10μM |
STK10-1-E | Serine/threonine-protein Kinase 10 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 110 | 0.36 | Binding ≤ 10μM |
STK16-1-E | Serine/threonine-protein Kinase 16 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 140 | 0.36 | Binding ≤ 10μM |
STK24-1-E | Serine/threonine-protein Kinase 24 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 180 | 0.35 | Binding ≤ 10μM |
STK25-1-E | Serine/threonine-protein Kinase 25 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 360 | 0.33 | Binding ≤ 10μM |
STK3-1-E | Serine/threonine-protein Kinase MST2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 61 | 0.37 | Binding ≤ 10μM |
STK4-1-E | Serine/threonine-protein Kinase MST1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 130 | 0.36 | Binding ≤ 10μM |
TEC-1-E | Tyrosine-protein Kinase TEC (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1000 | 0.31 | Binding ≤ 10μM |
TESK1-1-E | Dual Specificity Testis-specific Protein Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3100 | 0.29 | Binding ≤ 10μM |
TIE1-1-E | Tyrosine-protein Kinase Receptor Tie-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 260 | 0.34 | Binding ≤ 10μM |
TIE2-1-E | Tyrosine-protein Kinase TIE-2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 950 | 0.31 | Binding ≤ 10μM |
TLK1-1-E | Serine/threonine-protein Kinase Tousled-like 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1100 | 0.31 | Binding ≤ 10μM |
TLK2-1-E | Serine/threonine-protein Kinase Tousled-like 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 750 | 0.32 | Binding ≤ 10μM |
TNI3K-1-E | Serine/threonine-protein Kinase TNNI3K (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.30 | Binding ≤ 10μM |
TTK-1-E | Dual Specificity Protein Kinase TTK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 190 | 0.35 | Binding ≤ 10μM |
TYK2-1-E | Tyrosine-protein Kinase TYK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 32 | 0.39 | Binding ≤ 10μM |
UFO-1-E | Tyrosine-protein Kinase Receptor UFO (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2200 | 0.29 | Binding ≤ 10μM |
VGFR1-1-E | Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.29 | Binding ≤ 10μM |
VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3700 | 0.28 | Binding ≤ 10μM |
VGFR3-1-E | Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1100 | 0.31 | Binding ≤ 10μM |
Z104295-1-O | Cyclin-dependent Kinase 4/cyclin D1 (cluster #1 Of 2), Other | Other | 110 | 0.36 | Binding ≤ 10μM |
Z80018-2-O | A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other | Other | 450 | 0.33 | Functional ≤ 10μM |
Z80390-1-O | PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other | Other | 120 | 0.36 | Functional ≤ 10μM |
Z80493-1-O | SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other | Other | 750 | 0.32 | Functional ≤ 10μM |
Z80928-3-O | HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other | Other | 254 | 0.34 | Functional ≤ 10μM |
Z81247-1-O | HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other | Other | 284 | 0.34 | Functional ≤ 10μM |
Z81252-3-O | MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other | Other | 590 | 0.32 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AAK1_HUMAN | Q2M2I8 | Adaptor-associated Kinase, Human | 200 | 0.35 | Binding ≤ 1μM |
ANKK1_HUMAN | Q8NFD2 | Ankyrin Repeat And Protein Kinase Domain-containing Protein 1, Human | 500 | 0.33 | Binding ≤ 1μM |
BMP2K_HUMAN | Q9NSY1 | BMP-2-inducible Protein Kinase, Human | 180 | 0.35 | Binding ≤ 1μM |
BMPR2_HUMAN | Q13873 | Bone Morphogenetic Protein Receptor Type-2, Human | 880 | 0.31 | Binding ≤ 1μM |
KC1G2_HUMAN | P78368 | Casein Kinase I Gamma 2, Human | 740 | 0.32 | Binding ≤ 1μM |
CCNA1_HUMAN | P78396 | Cyclin A1, Human | 2 | 0.45 | Binding ≤ 1μM |
CCNA2_HUMAN | P20248 | Cyclin A2, Human | 2 | 0.45 | Binding ≤ 1μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 6 | 0.43 | Binding ≤ 1μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 2 | 0.45 | Binding ≤ 1μM |
CDK3_HUMAN | Q00526 | Cyclin-dependent Kinase 3, Human | 180 | 0.35 | Binding ≤ 1μM |
Z104295 | Z104295 | Cyclin-dependent Kinase 4/cyclin D1 | 110 | 0.36 | Binding ≤ 1μM |
CDK5_HUMAN | Q00535 | Cyclin-dependent Kinase 5, Human | 240 | 0.34 | Binding ≤ 1μM |
CDK7_HUMAN | P50613 | Cyclin-dependent Kinase 7, Human | 760 | 0.32 | Binding ≤ 1μM |
CDK9_HUMAN | P50750 | Cyclin-dependent Kinase 9, Human | 470 | 0.33 | Binding ≤ 1μM |
MP2K4_HUMAN | P45985 | Dual Specificity Mitogen-activated Protein Kinase Kinase 4, Human | 630 | 0.32 | Binding ≤ 1μM |
MP2K6_HUMAN | P52564 | Dual Specificity Mitogen-activated Protein Kinase Kinase 6, Human | 1000 | 0.31 | Binding ≤ 1μM |
CLK2_HUMAN | P49760 | Dual Specificity Protein Kinase CLK2, Human | 290 | 0.34 | Binding ≤ 1μM |
CLK3_HUMAN | P49761 | Dual Specificity Protein Kinase CLK3, Human | 310 | 0.34 | Binding ≤ 1μM |
TTK_HUMAN | P33981 | Dual Specificity Protein Kinase TTK, Human | 190 | 0.35 | Binding ≤ 1μM |
CLK1_HUMAN | P49759 | Dual Specificty Protein Kinase CLK1, Human | 660 | 0.32 | Binding ≤ 1μM |
FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 810 | 0.32 | Binding ≤ 1μM |
FGFR2_HUMAN | P21802 | Fibroblast Growth Factor Receptor 2, Human | 220 | 0.35 | Binding ≤ 1μM |
FGFR3_HUMAN | P22607 | Fibroblast Growth Factor Receptor 3, Human | 510 | 0.33 | Binding ≤ 1μM |
CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 6 | 0.43 | Binding ≤ 1μM |
CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 6 | 0.43 | Binding ≤ 1μM |
CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 6 | 0.43 | Binding ≤ 1μM |
GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 160 | 0.35 | Binding ≤ 1μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 41 | 0.38 | Binding ≤ 1μM |
MET_HUMAN | P08581 | Hepatocyte Growth Factor Receptor, Human | 650 | 0.32 | Binding ≤ 1μM |
LIMK1_HUMAN | P53667 | LIM Domain Kinase 1, Human | 620 | 0.32 | Binding ≤ 1μM |
LIMK2_HUMAN | P53671 | LIM Domain Kinase 2, Human | 1000 | 0.31 | Binding ≤ 1μM |
MARK4_HUMAN | Q96L34 | MAP/microtubule Affinity-regulating Kinase 4, Human | 660 | 0.32 | Binding ≤ 1μM |
MK06_HUMAN | Q16659 | Mitogen-activated Protein Kinase 6, Human | 480 | 0.33 | Binding ≤ 1μM |
MK07_HUMAN | Q13164 | Mitogen-activated Protein Kinase 7, Human | 520 | 0.33 | Binding ≤ 1μM |
M4K1_HUMAN | Q92918 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1, Human | 120 | 0.36 | Binding ≤ 1μM |
M4K3_HUMAN | Q8IVH8 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3, Human | 820 | 0.32 | Binding ≤ 1μM |
NUAK1_HUMAN | O60285 | NUAK Family SNF1-like Kinase 1, Human | 180 | 0.35 | Binding ≤ 1μM |
NUAK2_HUMAN | Q9H093 | NUAK Family SNF1-like Kinase 2, Human | 26 | 0.39 | Binding ≤ 1μM |
CD11B_HUMAN | P21127 | PITSLRE Serine/threonine-protein Kinase CDC2L1, Human | 150 | 0.35 | Binding ≤ 1μM |
CD11A_HUMAN | Q9UQ88 | PITSLRE Serine/threonine-protein Kinase CDC2L2, Human | 110 | 0.36 | Binding ≤ 1μM |
PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 910 | 0.31 | Binding ≤ 1μM |
KS6A2_HUMAN | Q15349 | Ribosomal Protein S6 Kinase Alpha 2, Human | 410 | 0.33 | Binding ≤ 1μM |
STK10_HUMAN | O94804 | Serine/threonine-protein Kinase 10, Human | 110 | 0.36 | Binding ≤ 1μM |
STK16_HUMAN | O75716 | Serine/threonine-protein Kinase 16, Human | 140 | 0.36 | Binding ≤ 1μM |
SLK_HUMAN | Q9H2G2 | Serine/threonine-protein Kinase 2, Human | 48 | 0.38 | Binding ≤ 1μM |
STK24_HUMAN | Q9Y6E0 | Serine/threonine-protein Kinase 24, Human | 180 | 0.35 | Binding ≤ 1μM |
STK25_HUMAN | O00506 | Serine/threonine-protein Kinase 25, Human | 360 | 0.33 | Binding ≤ 1μM |
AURKA_HUMAN | O14965 | Serine/threonine-protein Kinase Aurora-A, Human | 250 | 0.34 | Binding ≤ 1μM |
AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 160 | 0.35 | Binding ≤ 1μM |
AURKC_HUMAN | Q9UQB9 | Serine/threonine-protein Kinase Aurora-C, Human | 86 | 0.37 | Binding ≤ 1μM |
MARK3_HUMAN | P27448 | Serine/threonine-protein Kinase C-TAK1, Human | 600 | 0.32 | Binding ≤ 1μM |
MARK1_HUMAN | Q9P0L2 | Serine/threonine-protein Kinase MARK1, Human | 620 | 0.32 | Binding ≤ 1μM |
STK4_HUMAN | Q13043 | Serine/threonine-protein Kinase MST1, Human | 130 | 0.36 | Binding ≤ 1μM |
STK3_HUMAN | Q13188 | Serine/threonine-protein Kinase MST2, Human | 61 | 0.37 | Binding ≤ 1μM |
MST4_HUMAN | Q9P289 | Serine/threonine-protein Kinase MST4, Human | 210 | 0.35 | Binding ≤ 1μM |
PAK7_HUMAN | Q9P286 | Serine/threonine-protein Kinase PAK7, Human | 830 | 0.32 | Binding ≤ 1μM |
CDK16_HUMAN | Q00536 | Serine/threonine-protein Kinase PCTAIRE-1, Human | 23 | 0.40 | Binding ≤ 1μM |
CDK17_HUMAN | Q00537 | Serine/threonine-protein Kinase PCTAIRE-2, Human | 290 | 0.34 | Binding ≤ 1μM |
PLK4_HUMAN | O00444 | Serine/threonine-protein Kinase PLK4, Human | 120 | 0.36 | Binding ≤ 1μM |
TLK2_HUMAN | Q86UE8 | Serine/threonine-protein Kinase Tousled-like 2, Human | 750 | 0.32 | Binding ≤ 1μM |
KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 590 | 0.32 | Binding ≤ 1μM |
ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 68 | 0.37 | Binding ≤ 1μM |
JAK1_HUMAN | P23458 | Tyrosine-protein Kinase JAK1, Human | 21 | 0.40 | Binding ≤ 1μM |
JAK2_HUMAN | O60674 | Tyrosine-protein Kinase JAK2, Human | 220 | 0.35 | Binding ≤ 1μM |
JAK3_HUMAN | P52333 | Tyrosine-protein Kinase JAK3, Human | 180 | 0.35 | Binding ≤ 1μM |
FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 590 | 0.32 | Binding ≤ 1μM |
RET_HUMAN | P07949 | Tyrosine-protein Kinase Receptor RET, Human | 1000 | 0.31 | Binding ≤ 1μM |
TIE1_HUMAN | P35590 | Tyrosine-protein Kinase Receptor Tie-1, Human | 260 | 0.34 | Binding ≤ 1μM |
TEC_HUMAN | P42680 | Tyrosine-protein Kinase TEC, Human | 1000 | 0.31 | Binding ≤ 1μM |
TIE2_HUMAN | Q02763 | Tyrosine-protein Kinase TIE-2, Human | 950 | 0.31 | Binding ≤ 1μM |
TYK2_HUMAN | P29597 | Tyrosine-protein Kinase TYK2, Human | 32 | 0.39 | Binding ≤ 1μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 130 | 0.36 | Binding ≤ 1μM |
VGFR2_MOUSE | P35918 | Vascular Endothelial Growth Factor Receptor 2, Mouse | 130 | 0.36 | Binding ≤ 1μM |
PDPK1_HUMAN | O15530 | 3-phosphoinositide Dependent Protein Kinase-1, Human | 3100 | 0.29 | Binding ≤ 10μM |
ACVR1_HUMAN | Q04771 | Activin Receptor Type-1, Human | 5900 | 0.27 | Binding ≤ 10μM |
AVR2A_HUMAN | P27037 | Activin Receptor Type-2A, Human | 2900 | 0.29 | Binding ≤ 10μM |
AVR2B_HUMAN | Q13705 | Activin Receptor Type-2B, Human | 5900 | 0.27 | Binding ≤ 10μM |
AAK1_HUMAN | Q2M2I8 | Adaptor-associated Kinase, Human | 200 | 0.35 | Binding ≤ 10μM |
ALK_HUMAN | Q9UM73 | ALK Tyrosine Kinase Receptor, Human | 7100 | 0.27 | Binding ≤ 10μM |
AAPK1_HUMAN | Q13131 | AMP-activated Protein Kinase, Alpha-1 Subunit, Human | 1700 | 0.30 | Binding ≤ 10μM |
AAPK2_HUMAN | P54646 | AMP-activated Protein Kinase, Alpha-2 Subunit, Human | 1800 | 0.30 | Binding ≤ 10μM |
ANKK1_HUMAN | Q8NFD2 | Ankyrin Repeat And Protein Kinase Domain-containing Protein 1, Human | 500 | 0.33 | Binding ≤ 10μM |
BMP2K_HUMAN | Q9NSY1 | BMP-2-inducible Protein Kinase, Human | 180 | 0.35 | Binding ≤ 10μM |
BMPR2_HUMAN | Q13873 | Bone Morphogenetic Protein Receptor Type-2, Human | 880 | 0.31 | Binding ≤ 10μM |
BRSK1_HUMAN | Q8TDC3 | BR Serine/threonine-protein Kinase 1, Human | 6500 | 0.27 | Binding ≤ 10μM |
BRSK2_HUMAN | Q8IWQ3 | BR Serine/threonine-protein Kinase 2, Human | 2700 | 0.29 | Binding ≤ 10μM |
MK08_HUMAN | P45983 | C-Jun N-terminal Kinase 1, Human | 1700 | 0.30 | Binding ≤ 10μM |
MK10_HUMAN | P53779 | C-Jun N-terminal Kinase 3, Human | 1300 | 0.31 | Binding ≤ 10μM |
KKCC1_HUMAN | Q8N5S9 | CaM-kinase Kinase Alpha, Human | 2900 | 0.29 | Binding ≤ 10μM |
KKCC2_HUMAN | Q96RR4 | CaM-kinase Kinase Beta, Human | 2600 | 0.29 | Binding ≤ 10μM |
KC1E_HUMAN | P49674 | Casein Kinase I Epsilon, Human | 3600 | 0.28 | Binding ≤ 10μM |
KC1G1_HUMAN | Q9HCP0 | Casein Kinase I Gamma 1, Human | 1200 | 0.31 | Binding ≤ 10μM |
KC1G2_HUMAN | P78368 | Casein Kinase I Gamma 2, Human | 740 | 0.32 | Binding ≤ 10μM |
KC1G3_HUMAN | Q9Y6M4 | Casein Kinase I Isoform Gamma-3, Human | 7900 | 0.26 | Binding ≤ 10μM |
CSK22_HUMAN | P19784 | Casein Kinase II Alpha (prime), Human | 2000 | 0.30 | Binding ≤ 10μM |
ADCK3_HUMAN | Q8NI60 | Chaperone Activity Of Bc1 Complex-like, Mitochondrial, Human | 1200 | 0.31 | Binding ≤ 10μM |
CCNA1_HUMAN | P78396 | Cyclin A1, Human | 2 | 0.45 | Binding ≤ 10μM |
CCNA2_HUMAN | P20248 | Cyclin A2, Human | 2 | 0.45 | Binding ≤ 10μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 6 | 0.43 | Binding ≤ 10μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 2 | 0.45 | Binding ≤ 10μM |
CDK3_HUMAN | Q00526 | Cyclin-dependent Kinase 3, Human | 180 | 0.35 | Binding ≤ 10μM |
Z104295 | Z104295 | Cyclin-dependent Kinase 4/cyclin D1 | 110 | 0.36 | Binding ≤ 10μM |
CDK5_HUMAN | Q00535 | Cyclin-dependent Kinase 5, Human | 240 | 0.34 | Binding ≤ 10μM |
CDK7_HUMAN | P50613 | Cyclin-dependent Kinase 7, Human | 760 | 0.32 | Binding ≤ 10μM |
CDK9_HUMAN | P50750 | Cyclin-dependent Kinase 9, Human | 470 | 0.33 | Binding ≤ 10μM |
DAPK3_HUMAN | O43293 | Death-associated Protein Kinase 3, Human | 5200 | 0.27 | Binding ≤ 10μM |
MP2K1_HUMAN | Q02750 | Dual Specificity Mitogen-activated Protein Kinase Kinase 1, Human | 1800 | 0.30 | Binding ≤ 10μM |
MP2K2_HUMAN | P36507 | Dual Specificity Mitogen-activated Protein Kinase Kinase 2, Human | 5600 | 0.27 | Binding ≤ 10μM |
MP2K3_HUMAN | P46734 | Dual Specificity Mitogen-activated Protein Kinase Kinase 3, Human | 1500 | 0.30 | Binding ≤ 10μM |
MP2K4_HUMAN | P45985 | Dual Specificity Mitogen-activated Protein Kinase Kinase 4, Human | 630 | 0.32 | Binding ≤ 10μM |
MP2K6_HUMAN | P52564 | Dual Specificity Mitogen-activated Protein Kinase Kinase 6, Human | 1000 | 0.31 | Binding ≤ 10μM |
CLK2_HUMAN | P49760 | Dual Specificity Protein Kinase CLK2, Human | 290 | 0.34 | Binding ≤ 10μM |
CLK3_HUMAN | P49761 | Dual Specificity Protein Kinase CLK3, Human | 310 | 0.34 | Binding ≤ 10μM |
CLK4_HUMAN | Q9HAZ1 | Dual Specificity Protein Kinase CLK4, Human | 1700 | 0.30 | Binding ≤ 10μM |
TTK_HUMAN | P33981 | Dual Specificity Protein Kinase TTK, Human | 190 | 0.35 | Binding ≤ 10μM |
TESK1_HUMAN | Q15569 | Dual Specificity Testis-specific Protein Kinase 1, Human | 3100 | 0.29 | Binding ≤ 10μM |
CLK1_HUMAN | P49759 | Dual Specificty Protein Kinase CLK1, Human | 660 | 0.32 | Binding ≤ 10μM |
EPHA7_HUMAN | Q15375 | Ephrin Type-A Receptor 7, Human | 3100 | 0.29 | Binding ≤ 10μM |
E2AK4_HUMAN | Q9P2K8 | Eukaryotic Translation Initiation Factor 2-alpha Kinase 4, Human | 3900 | 0.28 | Binding ≤ 10μM |
FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 810 | 0.32 | Binding ≤ 10μM |
FGFR2_HUMAN | P21802 | Fibroblast Growth Factor Receptor 2, Human | 220 | 0.35 | Binding ≤ 10μM |
FGFR3_HUMAN | P22607 | Fibroblast Growth Factor Receptor 3, Human | 510 | 0.33 | Binding ≤ 10μM |
CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 6 | 0.43 | Binding ≤ 10μM |
CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 6 | 0.43 | Binding ≤ 10μM |
CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 6 | 0.43 | Binding ≤ 10μM |
GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 160 | 0.35 | Binding ≤ 10μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 41 | 0.38 | Binding ≤ 10μM |
MET_HUMAN | P08581 | Hepatocyte Growth Factor Receptor, Human | 650 | 0.32 | Binding ≤ 10μM |
IKKE_HUMAN | Q14164 | Inhibitor Of Nuclear Factor Kappa B Kinase Epsilon Subunit, Human | 8300 | 0.26 | Binding ≤ 10μM |
E2AK2_HUMAN | P19525 | Interferon-induced, Double-stranded RNA-activated Protein Kinase, Human | 6300 | 0.27 | Binding ≤ 10μM |
IRAK3_HUMAN | Q9Y616 | Interleukin-1 Receptor-associated Kinase 3, Human | 3400 | 0.28 | Binding ≤ 10μM |
LIMK1_HUMAN | P53667 | LIM Domain Kinase 1, Human | 620 | 0.32 | Binding ≤ 10μM |
LIMK2_HUMAN | P53671 | LIM Domain Kinase 2, Human | 1000 | 0.31 | Binding ≤ 10μM |
CSF1R_HUMAN | P07333 | Macrophage Colony Stimulating Factor Receptor, Human | 4200 | 0.28 | Binding ≤ 10μM |
MARK2_HUMAN | Q7KZI7 | MAP/microtubule Affinity-regulating Kinase 2, Human | 1200 | 0.31 | Binding ≤ 10μM |
MARK4_HUMAN | Q96L34 | MAP/microtubule Affinity-regulating Kinase 4, Human | 660 | 0.32 | Binding ≤ 10μM |
MK15_HUMAN | Q8TD08 | Mitogen-activated Protein Kinase 15, Human | 1100 | 0.31 | Binding ≤ 10μM |
MK04_HUMAN | P31152 | Mitogen-activated Protein Kinase 4, Human | 1600 | 0.30 | Binding ≤ 10μM |
MK06_HUMAN | Q16659 | Mitogen-activated Protein Kinase 6, Human | 480 | 0.33 | Binding ≤ 10μM |
MK07_HUMAN | Q13164 | Mitogen-activated Protein Kinase 7, Human | 520 | 0.33 | Binding ≤ 10μM |
M3K9_HUMAN | P80192 | Mitogen-activated Protein Kinase Kinase Kinase 9, Human | 3600 | 0.28 | Binding ≤ 10μM |
M4K1_HUMAN | Q92918 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1, Human | 120 | 0.36 | Binding ≤ 10μM |
M4K3_HUMAN | Q8IVH8 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3, Human | 820 | 0.32 | Binding ≤ 10μM |
M4K5_HUMAN | Q9Y4K4 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5, Human | 2100 | 0.29 | Binding ≤ 10μM |
MYLK_HUMAN | Q15746 | Myosin Light Chain Kinase, Smooth Muscle, Human | 2100 | 0.29 | Binding ≤ 10μM |
DMPK_HUMAN | Q09013 | Myotonin-protein Kinase, Human | 1200 | 0.31 | Binding ≤ 10μM |
NUAK1_HUMAN | O60285 | NUAK Family SNF1-like Kinase 1, Human | 180 | 0.35 | Binding ≤ 10μM |
NUAK2_HUMAN | Q9H093 | NUAK Family SNF1-like Kinase 2, Human | 26 | 0.39 | Binding ≤ 10μM |
PI51A_HUMAN | Q99755 | Phosphatidylinositol-4-phosphate 5-kinase Type-1 Alpha, Human | 9200 | 0.26 | Binding ≤ 10μM |
PI42B_HUMAN | P78356 | Phosphatidylinositol-5-phosphate 4-kinase Type-2 Beta, Human | 1300 | 0.31 | Binding ≤ 10μM |
CD11B_HUMAN | P21127 | PITSLRE Serine/threonine-protein Kinase CDC2L1, Human | 150 | 0.35 | Binding ≤ 10μM |
CD11A_HUMAN | Q9UQ88 | PITSLRE Serine/threonine-protein Kinase CDC2L2, Human | 110 | 0.36 | Binding ≤ 10μM |
PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 4000 | 0.28 | Binding ≤ 10μM |
PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 910 | 0.31 | Binding ≤ 10μM |
KPCD_HUMAN | Q05655 | Protein Kinase C Delta, Human | 4500 | 0.28 | Binding ≤ 10μM |
KPCD1_HUMAN | Q15139 | Protein Kinase C Mu, Human | 8400 | 0.26 | Binding ≤ 10μM |
KPCD3_HUMAN | O94806 | Protein Kinase C Nu, Human | 4200 | 0.28 | Binding ≤ 10μM |
KPCT_HUMAN | Q04759 | Protein Kinase C Theta, Human | 4400 | 0.28 | Binding ≤ 10μM |
PKN2_HUMAN | Q16513 | Protein Kinase N2, Human | 1900 | 0.30 | Binding ≤ 10μM |
MERTK_HUMAN | Q12866 | Proto-oncogene Tyrosine-protein Kinase MER, Human | 2800 | 0.29 | Binding ≤ 10μM |
RIPK1_HUMAN | Q13546 | Receptor-interacting Serine/threonine-protein Kinase 1, Human | 1800 | 0.30 | Binding ≤ 10μM |
KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 4000 | 0.28 | Binding ≤ 10μM |
KS6A2_HUMAN | Q15349 | Ribosomal Protein S6 Kinase Alpha 2, Human | 410 | 0.33 | Binding ≤ 10μM |
KS6A4_HUMAN | O75676 | Ribosomal Protein S6 Kinase Alpha 4, Human | 3000 | 0.29 | Binding ≤ 10μM |
STK10_HUMAN | O94804 | Serine/threonine-protein Kinase 10, Human | 110 | 0.36 | Binding ≤ 10μM |
STK16_HUMAN | O75716 | Serine/threonine-protein Kinase 16, Human | 140 | 0.36 | Binding ≤ 10μM |
ST17A_HUMAN | Q9UEE5 | Serine/threonine-protein Kinase 17A, Human | 5600 | 0.27 | Binding ≤ 10μM |
SLK_HUMAN | Q9H2G2 | Serine/threonine-protein Kinase 2, Human | 48 | 0.38 | Binding ≤ 10μM |
STK24_HUMAN | Q9Y6E0 | Serine/threonine-protein Kinase 24, Human | 180 | 0.35 | Binding ≤ 10μM |
STK25_HUMAN | O00506 | Serine/threonine-protein Kinase 25, Human | 360 | 0.33 | Binding ≤ 10μM |
AURKA_HUMAN | O14965 | Serine/threonine-protein Kinase Aurora-A, Human | 250 | 0.34 | Binding ≤ 10μM |
AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 160 | 0.35 | Binding ≤ 10μM |
AURKC_HUMAN | Q9UQB9 | Serine/threonine-protein Kinase Aurora-C, Human | 86 | 0.37 | Binding ≤ 10μM |
MARK3_HUMAN | P27448 | Serine/threonine-protein Kinase C-TAK1, Human | 600 | 0.32 | Binding ≤ 10μM |
DCLK1_HUMAN | O15075 | Serine/threonine-protein Kinase DCLK1, Human | 2500 | 0.29 | Binding ≤ 10μM |
DCLK2_HUMAN | Q8N568 | Serine/threonine-protein Kinase DCLK2, Human | 4500 | 0.28 | Binding ≤ 10μM |
DCLK3_HUMAN | Q9C098 | Serine/threonine-protein Kinase DCLK3, Human | 6500 | 0.27 | Binding ≤ 10μM |
GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 2400 | 0.29 | Binding ≤ 10μM |
MARK1_HUMAN | Q9P0L2 | Serine/threonine-protein Kinase MARK1, Human | 620 | 0.32 | Binding ≤ 10μM |
STK4_HUMAN | Q13043 | Serine/threonine-protein Kinase MST1, Human | 130 | 0.36 | Binding ≤ 10μM |
STK3_HUMAN | Q13188 | Serine/threonine-protein Kinase MST2, Human | 61 | 0.37 | Binding ≤ 10μM |
MST4_HUMAN | Q9P289 | Serine/threonine-protein Kinase MST4, Human | 210 | 0.35 | Binding ≤ 10μM |
PAK3_HUMAN | O75914 | Serine/threonine-protein Kinase PAK 3, Human | 2100 | 0.29 | Binding ≤ 10μM |
PAK4_HUMAN | O96013 | Serine/threonine-protein Kinase PAK 4, Human | 2300 | 0.29 | Binding ≤ 10μM |
PAK6_HUMAN | Q9NQU5 | Serine/threonine-protein Kinase PAK6, Human | 1400 | 0.30 | Binding ≤ 10μM |
PAK7_HUMAN | Q9P286 | Serine/threonine-protein Kinase PAK7, Human | 830 | 0.32 | Binding ≤ 10μM |
CDK16_HUMAN | Q00536 | Serine/threonine-protein Kinase PCTAIRE-1, Human | 23 | 0.40 | Binding ≤ 10μM |
CDK17_HUMAN | Q00537 | Serine/threonine-protein Kinase PCTAIRE-2, Human | 290 | 0.34 | Binding ≤ 10μM |
CDK18_HUMAN | Q07002 | Serine/threonine-protein Kinase PCTAIRE-3, Human | 2100 | 0.29 | Binding ≤ 10μM |
CDK14_HUMAN | O94921 | Serine/threonine-protein Kinase PFTAIRE-1, Human | 3600 | 0.28 | Binding ≤ 10μM |
PLK1_HUMAN | P53350 | Serine/threonine-protein Kinase PLK1, Human | 5000 | 0.27 | Binding ≤ 10μM |
PLK3_HUMAN | Q9H4B4 | Serine/threonine-protein Kinase PLK3, Human | 7100 | 0.27 | Binding ≤ 10μM |
PLK4_HUMAN | O00444 | Serine/threonine-protein Kinase PLK4, Human | 120 | 0.36 | Binding ≤ 10μM |
ACVL1_HUMAN | P37023 | Serine/threonine-protein Kinase Receptor R3, Human | 2900 | 0.29 | Binding ≤ 10μM |
RIOK1_HUMAN | Q9BRS2 | Serine/threonine-protein Kinase RIO1, Human | 1100 | 0.31 | Binding ≤ 10μM |
RIOK3_HUMAN | O14730 | Serine/threonine-protein Kinase RIO3, Human | 1200 | 0.31 | Binding ≤ 10μM |
SIK1_HUMAN | P57059 | Serine/threonine-protein Kinase SIK1, Human | 2200 | 0.29 | Binding ≤ 10μM |
SIK2_HUMAN | Q9H0K1 | Serine/threonine-protein Kinase SIK2, Human | 1600 | 0.30 | Binding ≤ 10μM |
SRPK1_HUMAN | Q96SB4 | Serine/threonine-protein Kinase SRPK1, Human | 2800 | 0.29 | Binding ≤ 10μM |
TNI3K_HUMAN | Q59H18 | Serine/threonine-protein Kinase TNNI3K, Human | 1400 | 0.30 | Binding ≤ 10μM |
TLK1_HUMAN | Q9UKI8 | Serine/threonine-protein Kinase Tousled-like 1, Human | 1100 | 0.31 | Binding ≤ 10μM |
TLK2_HUMAN | Q86UE8 | Serine/threonine-protein Kinase Tousled-like 2, Human | 750 | 0.32 | Binding ≤ 10μM |
KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 1400 | 0.30 | Binding ≤ 10μM |
ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 1200 | 0.31 | Binding ≤ 10μM |
BMX_HUMAN | P51813 | Tyrosine-protein Kinase BMX, Human | 4700 | 0.28 | Binding ≤ 10μM |
FGR_HUMAN | P09769 | Tyrosine-protein Kinase FGR, Human | 2000 | 0.30 | Binding ≤ 10μM |
JAK1_HUMAN | P23458 | Tyrosine-protein Kinase JAK1, Human | 21 | 0.40 | Binding ≤ 10μM |
JAK2_HUMAN | O60674 | Tyrosine-protein Kinase JAK2, Human | 220 | 0.35 | Binding ≤ 10μM |
JAK3_HUMAN | P52333 | Tyrosine-protein Kinase JAK3, Human | 180 | 0.35 | Binding ≤ 10μM |
FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 1400 | 0.30 | Binding ≤ 10μM |
RET_HUMAN | P07949 | Tyrosine-protein Kinase Receptor RET, Human | 1000 | 0.31 | Binding ≤ 10μM |
TIE1_HUMAN | P35590 | Tyrosine-protein Kinase Receptor Tie-1, Human | 260 | 0.34 | Binding ≤ 10μM |
UFO_HUMAN | P30530 | Tyrosine-protein Kinase Receptor UFO, Human | 2200 | 0.29 | Binding ≤ 10μM |
KSYK_HUMAN | P43405 | Tyrosine-protein Kinase SYK, Human | 1300 | 0.31 | Binding ≤ 10μM |
TEC_HUMAN | P42680 | Tyrosine-protein Kinase TEC, Human | 1000 | 0.31 | Binding ≤ 10μM |
TIE2_HUMAN | Q02763 | Tyrosine-protein Kinase TIE-2, Human | 950 | 0.31 | Binding ≤ 10μM |
TYK2_HUMAN | P29597 | Tyrosine-protein Kinase TYK2, Human | 32 | 0.39 | Binding ≤ 10μM |
VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 2100 | 0.29 | Binding ≤ 10μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 130 | 0.36 | Binding ≤ 10μM |
VGFR2_MOUSE | P35918 | Vascular Endothelial Growth Factor Receptor 2, Mouse | 130 | 0.36 | Binding ≤ 10μM |
VGFR3_HUMAN | P35916 | Vascular Endothelial Growth Factor Receptor 3, Human | 1100 | 0.31 | Binding ≤ 10μM |
Z80018 | Z80018 | A-375 (Malignant Melanoma Cells) | 447 | 0.33 | Functional ≤ 10μM |
Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 250 | 0.34 | Functional ≤ 10μM |
Z81247 | Z81247 | HeLa (Cervical Adenocarcinoma Cells) | 280 | 0.34 | Functional ≤ 10μM |
Z81252 | Z81252 | MDA-MB-231 (Breast Adenocarcinoma Cells) | 590 | 0.32 | Functional ≤ 10μM |
Z80390 | Z80390 | PC-3 (Prostate Carcinoma Cells) | 120 | 0.36 | Functional ≤ 10μM |
Z80493 | Z80493 | SK-OV-3 (Ovarian Carcinoma Cells) | 750 | 0.32 | Functional ≤ 10μM |
Description | Species |
---|---|
Activated point mutants of FGFR2 | |
activated TAK1 mediates p38 MAPK activation | |
Activation of ATR in response to replication stress | |
Activation of BIM and translocation to mitochondria | |
Activation of BMF and translocation to mitochondria | |
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | |
Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
Activation of PKB | |
Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
Activation of Rac | |
Activation of the AP-1 family of transcription factors | |
Activation of the pre-replicative complex | |
AKT phosphorylates targets in the cytosol | |
AMPK inhibits chREBP transcriptional activation activity | |
Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
APC truncation mutants have impaired AXIN binding | |
APC/C:Cdc20 mediated degradation of Cyclin B | |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins | |
Apoptotic cleavage of cellular proteins | |
Apoptotic execution phase | |
AXIN missense mutants destabilize the destruction complex | |
Beta-catenin phosphorylation cascade | |
Calmodulin induced events | |
Caspase-8 activation by cleavage | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
CDK-mediated phosphorylation and removal of Cdc6 | |
CDO in myogenesis | |
Cell surface interactions at the vascular wall | |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |
Circadian Clock | |
Condensation of Prometaphase Chromosomes | |
Condensation of Prophase Chromosomes | |
Constitutive PI3K/AKT Signaling in Cancer | |
CREB phosphorylation | |
CREB phosphorylation through the activation of CaMKK | |
CREB phosphorylation through the activation of Ras | |
CRMPs in Sema3A signaling | |
CTLA4 inhibitory signaling | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin B2 mediated events | |
Cyclin D associated events in G1 | |
Cyclin E associated events during G1/S transition | |
DAG and IP3 signaling | |
DAP12 signaling | |
DARPP-32 events | |
Degradation of beta-catenin by the destruction complex | |
Depolymerisation of the Nuclear Lamina | |
Dimerization of procaspase-8 | |
disassembly of the destruction complex and recruitment of AXIN to the membrane | |
DNA Damage/Telomere Stress Induced Senescence | |
Downstream signal transduction | |
Downstream TCR signaling | |
DSCAM interactions | |
Dual incision reaction in GG-NER | |
Dual incision reaction in TC-NER | |
E2F mediated regulation of DNA replication | |
E2F-enabled inhibition of pre-replication complex formation | |
Effects of PIP2 hydrolysis | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
Ephrin signaling | |
ERK/MAPK targets | |
ERK1 activation | |
ERK2 activation | |
ERKs are inactivated | |
Factors involved in megakaryocyte development and platelet production | |
Fc epsilon receptor (FCERI) signaling | |
FCERI mediated Ca+2 mobilization | |
FCERI mediated MAPK activation | |
FCERI mediated NF-kB activation | |
FCGR activation | |
Formation of HIV elongation complex in the absence of HIV Tat | |
Formation of HIV-1 elongation complex containing HIV-1 Tat | |
Formation of incision complex in GG-NER | |
Formation of RNA Pol II elongation complex | |
Formation of the Early Elongation Complex | |
Formation of the HIV-1 Early Elongation Complex | |
Formation of transcription-coupled NER (TC-NER) repair complex | |
G alpha (z) signalling events | |
G beta:gamma signalling through PI3Kgamma | |
G0 and Early G1 | |
G1/S-Specific Transcription | |
G2 Phase | |
G2/M DNA replication checkpoint | |
Gastrin-CREB signalling pathway via PKC and MAPK | |
Generation of second messenger molecules | |
Golgi Associated Vesicle Biogenesis | |
Golgi Cisternae Pericentriolar Stack Reorganization | |
GPVI-mediated activation cascade | |
Growth hormone receptor signaling | |
HIV elongation arrest and recovery | |
HIV Transcription Initiation | |
HuR stabilizes mRNA | |
IKK complex recruitment mediated by RIP1 | |
Import of palmitoyl-CoA into the mitochondrial matrix | |
Inactivation, recovery and regulation of the phototransduction cascade | |
Inhibition of PKR | |
Integrin alphaIIb beta3 signaling | |
Integrin cell surface interactions | |
Interactions of Tat with host cellular proteins | |
Interferon alpha/beta signaling | |
Interferon gamma signaling | |
Interleukin receptor SHC signaling | |
Interleukin-1 signaling | |
Interleukin-2 signaling | |
Interleukin-3, 5 and GM-CSF signaling | |
Interleukin-6 signaling | |
Interleukin-7 signaling | |
ISG15 antiviral mechanism | |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
MASTL Facilitates Mitotic Progression | |
Meiotic recombination | |
MEK activation | |
misspliced GSK3beta mutants stabilize beta-catenin | |
Mitotic Metaphase/Anaphase Transition | |
Mitotic Prometaphase | |
Mitotic Telophase/Cytokinesis | |
mRNA Capping | |
MyD88:Mal cascade initiated on plasma membrane | |
Negative regulators of RIG-I/MDA5 signaling | |
Netrin-1 signaling | |
Neurophilin interactions with VEGF and VEGFR | |
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | |
NOD1/2 Signaling Pathway | |
NoRC negatively regulates rRNA expression | |
NRAGE signals death through JNK | |
NRIF signals cell death from the nucleus | |
Nuclear Pore Complex (NPC) Disassembly | |
Orc1 removal from chromatin | |
Oxidative Stress Induced Senescence | |
p53-Dependent G1 DNA Damage Response | |
Pausing and recovery of HIV elongation | |
Pausing and recovery of Tat-mediated HIV elongation | |
Phosphorylation of Emi1 | |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 com | |
Phosphorylation of the APC/C | |
PIP3 activates AKT signaling | |
Platelet sensitization by LDL | |
Polo-like kinase mediated events | |
Prolactin receptor signaling | |
RAF phosphorylates MEK | |
Recruitment of mitotic centrosome proteins and complexes | |
Recruitment of NuMA to mitotic centrosomes | |
Recycling pathway of L1 | |
Regulation by c-FLIP | |
Regulation of actin dynamics for phagocytic cup formation | |
Regulation of AMPK activity via LKB1 | |
Regulation of APC/C activators between G1/S and early anaphase | |
Regulation of cytoskeletal remodeling and cell spreading by IPP complex componen | |
Regulation of HSF1-mediated heat shock response | |
Regulation of IFNA signaling | |
Regulation of IFNG signaling | |
Regulation of KIT signaling | |
Regulation of PLK1 Activity at G2/M Transition | |
Regulation of Rheb GTPase activity by AMPK | |
Regulation of signaling by CBL | |
Regulation of signaling by NODAL | |
Resolution of Sister Chromatid Cohesion | |
RIP-mediated NFkB activation via ZBP1 | |
RMTs methylate histone arginines | |
RNA Pol II CTD phosphorylation and interaction with CE | |
RNA Polymerase I Chain Elongation | |
RNA Polymerase I Promoter Escape | |
RNA Polymerase I Transcription Initiation | |
RNA Polymerase I Transcription Termination | |
RNA Polymerase II HIV Promoter Escape | |
RNA Polymerase II Pre-transcription Events | |
RNA Polymerase II Promoter Escape | |
RNA Polymerase II Transcription Elongation | |
RNA Polymerase II Transcription Initiation | |
RNA Polymerase II Transcription Initiation And Promoter Clearance | |
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | |
Role of Abl in Robo-Slit signaling | |
Role of DCC in regulating apoptosis | |
Role of LAT2/NTAL/LAB on calcium mobilization | |
Role of phospholipids in phagocytosis | |
RSK activation | |
S33 mutants of beta-catenin aren't phosphorylated | |
S37 mutants of beta-catenin aren't phosphorylated | |
S45 mutants of beta-catenin aren't phosphorylated | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Sema3A PAK dependent Axon repulsion | |
Sema4D induced cell migration and growth-cone collapse | |
Sema4D mediated inhibition of cell attachment and migration | |
Senescence-Associated Secretory Phenotype (SASP) | |
Separation of Sister Chromatids | |
Signal transduction by L1 | |
Signaling by activated point mutants of FGFR1 | |
Signaling by activated point mutants of FGFR3 | |
Signaling by Activin | |
Signaling by BMP | |
Signaling by FGFR | |
Signaling by FGFR mutants | |
Signaling by FGFR2 amplification mutants | |
Signaling by FGFR3 mutants | |
Signaling by Hippo | |
Signaling by Leptin | |
Signaling by NODAL | |
Signaling by PDGF | |
Signaling by SCF-KIT | |
Signalling to ERK5 | |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | |
Smooth Muscle Contraction | |
Sphingolipid de novo biosynthesis | |
Synthesis of PIPs at the plasma membrane | |
t(4;14) translocations of FGFR3 | |
T41 mutants of beta-catenin aren't phosphorylated | |
Tat-mediated elongation of the HIV-1 transcript | |
Tat-mediated HIV elongation arrest and recovery | |
Tie2 Signaling | |
TNF signaling | |
TRAF3-dependent IRF activation pathway | |
TRAF6 mediated IRF7 activation | |
Transcription of the HIV genome | |
Translocation of GLUT4 to the plasma membrane | |
TRIF-mediated programmed cell death | |
TRP channels | |
truncations of AMER1 destabilize the destruction complex | |
Uptake and function of anthrax toxins | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation | |
VEGFR2 mediated vascular permeability | |
WNT mediated activation of DVL | |
XBP1(S) activates chaperone genes |